{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05394064",
            "orgStudyIdInfo": {
                "id": "SBT101-CT101"
            },
            "secondaryIdInfos": [
                {
                    "id": "2021-004410-19",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "SwanBio Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN)",
            "officialTitle": "A Phase 1/2 Randomized, Blinded, Dose-escalation Study to Evaluate the Safety and Efficacy of Intrathecal Administration of AAV9-ABCD1 Gene Therapy (SBT101) in Adult Patients With Adrenomyeloneuropathy",
            "acronym": "PROPEL",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-evaluate-administration-of-gene-therapy-in-adult-patients-with-adrenomyeloneuropathy-amn"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-11-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-03-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-03-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-05-16",
            "studyFirstSubmitQcDate": "2022-05-23",
            "studyFirstPostDateStruct": {
                "date": "2022-05-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-11",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "SwanBio Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a Phase 1/2 randomized, blinded, dose-escalation study to evaluate the safety and efficacy of intrathecal (IT) administration of SBT101, a recombinant adeno-associated virus serotype 9 (AAV9) containing a functional copy of the human adenosine triphosphate (ATP)-binding cassette transporter subfamily D member 1 (ABCD1; hABCD1) gene, in adult patients with adrenomyeloneuropathy (AMN) aged 18-65 years.\n\nPatients will receive a single dose of SBT101 via IT route (or an imitation procedure) and will be followed for safety and efficacy for 2 years. Patients receiving SBT101 will be followed for an additional 3 years (5 total) for Safety. Patients receiving an imitation procedure will be offered the opportunity to receive SBT101 after 2 years, as data indicate.",
            "detailedDescription": "The study consists of two parts after infusion of SBT101:\n\nPart 1: A blinded 24-month core study period to evaluate the safety and potential impact of SBT101 on disease progression. Part 1 will consist of 2 phases:\n\nPhase 1: Dose-Escalation Phase: Two (2) doses of SBT101 (Dose level 1 cohort and Dose Level 2 cohort) will be evaluated to establish the maximum tolerated dose (MTD).\n\nPhase 2: Dose-Expansion Phase: Additional patients will be enrolled to receive SBT101 at the MTD\n\nPart 2: An unblinded 3-year long-term safety follow-up period with annual follow-up visits to evaluate the safety of SBT101 and disease progression."
        },
        "conditionsModule": {
            "conditions": [
                "AMN",
                "AMN Gene Mutation",
                "X-ALD"
            ],
            "keywords": [
                "AMN",
                "X-ALD",
                "Adrenoleukodystrophy",
                "X-linked Adrenoleukodystrophy",
                "Adrenomyeloneuropathy",
                "Myeloneuropathy",
                "Spastic paraplegia",
                "Hereditary Spastic Paraplegia",
                "HSP",
                "ALD",
                "ABCD1",
                "ALDP",
                "CALD",
                "CCALD",
                "Brain Diseases, Metabolic, Inborn",
                "Brain Diseases, Metabolic",
                "Hereditary Central Nervous System Demyelinating Diseases",
                "Leukoencephalopathies",
                "Demyelinating Diseases",
                "Heredodegenerative Disorders, Nervous System",
                "Metabolism, Inborn Errors",
                "Peroxisomal Disorders",
                "Metabolic Diseases",
                "Adrenal Insufficiency",
                "Gene Therapy",
                "AAV9",
                "Adeno-Associated Vector"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "3 Cohorts, each with active treatment and 1 with imitation procedure",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "maskingDescription": "Maintain masking to all but those are perform the actual procedure",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 16,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Active Treatment",
                    "type": "EXPERIMENTAL",
                    "description": "Patients treated with SBT101",
                    "interventionNames": [
                        "Genetic: SBT101"
                    ]
                },
                {
                    "label": "Imitation Procedure",
                    "type": "SHAM_COMPARATOR",
                    "description": "Procedure that mimics treatment with SBT101, but does not infuse anything into the spinal cord",
                    "interventionNames": [
                        "Procedure: Imitation Procedure"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "GENETIC",
                    "name": "SBT101",
                    "description": "SBT101 Treatment",
                    "armGroupLabels": [
                        "Active Treatment"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Imitation Procedure",
                    "description": "Procedure that mimics SBT101 infusion, but contains no drug administered",
                    "armGroupLabels": [
                        "Imitation Procedure"
                    ],
                    "otherNames": [
                        "Sham Procedure"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Adverse Events to SBT101",
                    "description": "Safety and tolerability of SBT101 administration",
                    "timeFrame": "2 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Disease progression",
                    "description": "Characterize disease progression in adults diagnosed with AMN through serial clinical assessments of walking ability measured by 6-Minute Walk Test",
                    "timeFrame": "2 years"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Change in Quality of Life",
                    "description": "Characterize the change in multiple quality of life parameters over time using questionnaires including the Multiple Sclerosis Quality of Life-54 (MS-QOL)",
                    "timeFrame": "2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Diagnosed with X-linked adrenoleukodystrophy (ALD), including proven mutation in the ABCD1 gene through confirmatory genetic testing, and supported by elevated circulating VLCFA levels.\n2. Clinical evidence of spinal cord involvement but still able to ambulate independently\n\nExclusion Criteria:\n\n1. Evidence of or past diagnosis of inflammatory cerebral disease.\n2. 15 years or more have elapsed since the initial onset of myeloneuropathy manifestations such as walking or running difficulties, bladder dysfunction, increased muscular tone, spasticity, weakness, balance problems, etc.\n3. Contraindications for MRI procedure and/or contrast materials.\n4. Contraindication to steroids, sirolimus, tacrolimus, and/or anesthetic medications.\n5. Unstable adrenal function (e.g., untreated or inappropriately treated adrenal insufficiency).\n6. History of diabetes or abnormal fasting plasma glucose (\u2265126 mg/dL) or hemoglobin A1C \u22656.5%.\n7. Patients who have received a gene therapy.",
            "healthyVolunteers": false,
            "sex": "MALE",
            "genderBased": true,
            "genderDescription": "Based on genetic gender",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trial Recruitment",
                    "role": "CONTACT",
                    "phone": "267-417-6356",
                    "email": "clinicaltrials@swanbiotx.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of Massachusetts Chan Medical School",
                    "status": "RECRUITING",
                    "city": "Worcester",
                    "state": "Massachusetts",
                    "zip": "01655",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.26259,
                        "lon": -71.80229
                    }
                },
                {
                    "facility": "Amsterdam UMC",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Amsterdam",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 52.37403,
                        "lon": 4.88969
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000326",
                    "term": "Adrenoleukodystrophy"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020739",
                    "term": "Brain Diseases, Metabolic, Inborn"
                },
                {
                    "id": "D000001928",
                    "term": "Brain Diseases, Metabolic"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000020279",
                    "term": "Hereditary Central Nervous System Demyelinating Diseases"
                },
                {
                    "id": "D000056784",
                    "term": "Leukoencephalopathies"
                },
                {
                    "id": "D000003711",
                    "term": "Demyelinating Diseases"
                },
                {
                    "id": "D000038901",
                    "term": "Mental Retardation, X-Linked"
                },
                {
                    "id": "D000008607",
                    "term": "Intellectual Disability"
                },
                {
                    "id": "D000019954",
                    "term": "Neurobehavioral Manifestations"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000040181",
                    "term": "Genetic Diseases, X-Linked"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000020271",
                    "term": "Heredodegenerative Disorders, Nervous System"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000018901",
                    "term": "Peroxisomal Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000000309",
                    "term": "Adrenal Insufficiency"
                },
                {
                    "id": "D000000307",
                    "term": "Adrenal Gland Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12085",
                    "name": "Muscle Spasticity",
                    "relevance": "LOW"
                },
                {
                    "id": "M3677",
                    "name": "Adrenoleukodystrophy",
                    "asFound": "Adrenomyeloneuropathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6909",
                    "name": "Demyelinating Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13177",
                    "name": "Paraplegia",
                    "relevance": "LOW"
                },
                {
                    "id": "M18094",
                    "name": "Spastic Paraplegia, Hereditary",
                    "relevance": "LOW"
                },
                {
                    "id": "M3661",
                    "name": "Adrenal Insufficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M5205",
                    "name": "Brain Diseases, Metabolic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22498",
                    "name": "Brain Diseases, Metabolic, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M28591",
                    "name": "Leukoencephalopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M22092",
                    "name": "Heredodegenerative Disorders, Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M20939",
                    "name": "Peroxisomal Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M22099",
                    "name": "Hereditary Central Nervous System Demyelinating Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11589",
                    "name": "Intellectual Disability",
                    "relevance": "LOW"
                },
                {
                    "id": "M24774",
                    "name": "Mental Retardation, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "M21826",
                    "name": "Neurobehavioral Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M24877",
                    "name": "Genetic Diseases, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M3659",
                    "name": "Adrenal Gland Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T218",
                    "name": "Adrenomyeloneuropathy",
                    "asFound": "Adrenomyeloneuropathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5954",
                    "name": "X-linked Adrenoleukodystrophy",
                    "asFound": "Adrenomyeloneuropathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4421",
                    "name": "Paraplegia",
                    "relevance": "LOW"
                },
                {
                    "id": "T2781",
                    "name": "Hereditary Spastic Paraplegia",
                    "relevance": "LOW"
                },
                {
                    "id": "T3061",
                    "name": "Infantile-onset Ascending Hereditary Spastic Paralysis",
                    "relevance": "LOW"
                },
                {
                    "id": "T4503",
                    "name": "Peroxisomal Biogenesis Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M7992",
                    "name": "Epinephrine",
                    "relevance": "LOW"
                },
                {
                    "id": "M30371",
                    "name": "Racepinephrine",
                    "relevance": "LOW"
                },
                {
                    "id": "M211043",
                    "name": "Epinephryl borate",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}